World Running Out Of Antibiotics, Warns World Health Organisation

There’s a serious lack of new antibiotics under development to combat the growing threat of antimicrobial resistance

Most of the drugs currently in the clinical phase are modifications of existing classes of antibiotics and are only short-term solutions, WHO said.

(Photo: iStock)

Antibiotics that are currently in clinical development are insufficient to combat the growing threat of antimicrobial resistance, a World Health Organisation (WHO) report said.

Most of the drugs currently in the clinical phase are modifications of existing classes of antibiotics and are only short-term solutions, WHO said.

There are, however, very few potential treatment options. The growing resistant infections pose the greatest threat to health, including drug-resistant tuberculosis (TB) which kills around 2,50,000 people each year.

Also read: Is Your Poultry Pushing You Towards a Post-Antibiotic Era?

There are also very few oral antibiotics in the pipeline, yet these are essential formulations for treating infections outside hospitals or in resource-limited settings, the report said.

"Antimicrobial resistance is a global health emergency that will seriously jeopardise progress in modern medicine," Tedros Adhanom Ghebreyesus, Director-General of WHO, said in a statement on 20 September.

There is an urgent need for more investment in research and development for antibiotic-resistant infections including TB, otherwise we will be forced back to a time when people feared common infections and risked their lives from minor surgery.

Tedros Adhanom Ghebreyesus, Director-General, WHO

Besides TB, the WHO has also identified 12 classes of priority pathogens – including common infections like pneumonia or urinary tract infections – that are increasingly resistant to existing antibiotics and urgently in need of new treatments.

Among the newly identified 51 new antibiotics and biologicals in clinical development, only eight are classed by the WHO as innovative treatments that will add value to the current antibiotic treatment arsenal, it said.

"Pharmaceutical companies and researchers must urgently focus on new antibiotics against certain types of extremely serious infections that can kill patients in a matter of days because we have no line of defence," noted Suzanne Hill, Director of the Department of Essential Medicines at WHO.

Also read: Always Complete Antibiotic Courses? Study Says You May Opt Not to

(#TalkingStalking: Have you ever been stalked? Share your experience with The Quint and inspire others to shatter the silence surrounding stalking. Send your stories to [e-mail] or WhatsApp @ [phone])